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Hereditary diffuse leukoencephalopathy with spheroids (HDLS) is an autosomal dominant white matter disease
that causes adult-onset cognitive impairment. The clinical manifestations are a variable combination of person-
ality and behavioral changes, cognitive decline, parkinsonism, spasticity, and epilepsy. In 2012, mutations in the
gene encoding colony stimulating factor 1 receptor (CSF1R) were identified as the cause of HDLS. As the numbers
of reported mutations are limited, the understanding of whole pathogenesis needs accumulation of disease-
causing mutations with detailed clinical descriptions. We describe a Japanese family with autosomal dominant
adult-onset cognitive impairment and characteristic white matter lesions. Genetic testing revealed a novel
p.A792Dmutation in the tyrosine kinase domain of CSF1R in two affected family members. The symptom profile
of the present casesmostlymatched the previously reported cases, with the notable exceptions of late-onset and
long disease duration.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Hereditary diffuse leukoencephalopathywith spheroids (HDLS) was
first described by Axelsson et al. in 1984 [1]. It is an autosomal dominant
white matter disease with high penetrance that causes adult-onset
cognitive impairment. The clinical manifestations are a variable combi-
nation of personality and behavioral changes, cognitive decline, depres-
sion, parkinsonism, spasticity, and epilepsy. Cognitive decline and
parkinsonism are particularly common symptoms. The histopathologi-
cal hallmarks of HDLS are widespread leukoencephalopathy with
numerous neuroaxonal spheroids in the affectedwhitematter, accumu-
lation of pigmented microglia, and gliosis. Pigmented microglia poorly
express CSF1R and are distributed diffusely throughout the white mat-
ter in the early disease stage, preceding axonal degeneration andmyelin
loss [2].
In 2012, mutations in the gene encoding colony stimulating factor 1
receptor (CSF1R) were identified as the cause of HDLS [3]. Then, CSF1R
mutations linked two previously separate disease entities, HDLS and
pigmented orthochromatic leukodystrophy, as a single disease [4]. The
CSF1R mutations disturb autophosphorylation of tyrosine residues in
the cytoplasmic tyrosine kinase domain of CSF1R and result in the
partial loss of its function,which is important formicroglial proliferation
and differentiation in the brain [5]. Recently, it was suggested that
haploinsufficiency of CSF1R is sufficient to cause HDLS [6].
Several features on computed tomography (CT) or magnetic reso-
nance imaging (MRI) have been described in cases of genetically con-
firmed HDLS [7–9]. Subcortical calcifications on CT and restricted
diffusion on MRI have been reported as relatively specific findings [6,
9]. These characteristic findings of neuroimaging in addition to clinical
features help to distinguish HDLS from other white matter diseases.
Wedescribe a Japanese familywith autosomal dominant early-onset
dementia. Genetic testing revealed a novel p.A792D mutation in CSF1R.
The proband and other affected members initially exhibited personality
changes and executive dysfunction, which are characteristic for HDLS,
but the disease tended to be late-onset with a disease course of long
duration [2].
2. Case report
A 43-year-old man presented with a two-year history of cognitive
decline. He had a family history compatible with autosomal-dominant
early-onset dementia (Fig. 1). He had stopped participating in his favor-
ite sport and had become apathetic two years ago. He was an office
worker but had made mistakes in calculations and could not arrange
long-term plans. His colleagues did not notice personality changes, but
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he became irritable with his family and sometimes spoke too loudly. He
was unaware of the problems. On neurological examination, hewas po-
lite, and his appearance was clean. His Mini-Mental State Examination
(MMSE) and Frontal Assessment Battery (FAB) scores were 28/30 and
10/18, respectively; difficulties in orientation to time, digit span, and
word fluency were detected by these tests. Although aphasia, agnosia,
or apraxia was not detected, difficulty with abstract thinking was ob-
served to some extent. Visuospatial impairment was not apparent, and
the patient was able to copy the Rey–Osterrieth Complex Figure; how-
ever, each part of thefigurewas inefficiently copied. Thepatient showed
fewmotor symptoms. Dysarthria, dysphasia,weakness, spasticity, rigid-
ity, bradykinesia, gait disturbance, or involuntary movement was not
observed. Brain MRI revealed hyperintensity in the frontal-lobe-
dominant deep white matter and corpus callosum by FLAIR and also
marked atrophy (Fig. 2a). The white matter lesion partially showed
spotty diffusional limitation. The parietal and occipital lobes were rela-
tively preserved. Brain CT revealed refined calcifications in the basal
ganglia and deep white matter, especially along the bilateral frontal
horns of the lateral ventricle (Fig. 2b). 18F-fluorodeoxyglucose positron
emission tomography (FDG-PET) revealed hypometabolism throughout
the entire cerebral cortex, except for the motor area (Fig. 2c).
The father of the proband (II.1) presented literal paraphasia (towel
to scissor) as the first symptom in his fifties. He voluntarily went to
hospital and diagnosed as Pick disease at the age of 54. He had become
apathic, had difficulty to work. His family were suffering from his wan-
dering after 8 years. At the age of 65, he had difficulty in going to a toilet
and in eating, and died at the age of 69. The patient of II.4 presented cog-
nitive decline at the age of 53. He had become irritable, annoyed his
family with wandering about and died at the age of 60. The patient of
II.5 presented behavioral change around fifties, when she drove in the
opposite direction of an expressway. She has become bedridden and
hospitalized in a care hospital. The clinical course of patients I.2 is
unknown, because all his children were affected. Unfortunately, neuro-
imaging date of them has been lost.
3. Gene analysis
Because the patient had a family history of adult-onset cognitive im-
pairment suggestive of autosomal dominant inheritance and the char-
acteristic brain MRI for HDLS, we sequenced the CSF1R gene by using
the Sanger method. Genomic DNA was extracted from peripheral
blood leukocytes after informed consent and approval by IRB for re-
search ethics. The genetic analysis demonstrated a novel heterozygous
c.2375CNA, p.Ala792Asp mutation in exon 18 of CSF1R. The substituted
amino acid is located within the tyrosine kinase domain of CSF1R. Pro-
tein sequence alignment was performed with ClustalW, demonstrating
that the amino acid is conserved through theprocess of evolution in ver-
tebrates except for Xenopus tropicalis. The same mutation was also re-
vealed in the aunt of the proband, the only other patient from whom
DNA was available in this family at the time of the study (Fig. 3). The
Fig. 1. Family pedigree. Filled symbols indicate individuals affected by cognitive decline. An arrow indicates the proband. The age of onset in patient I-2 is unknown.
Fig. 2.Neuroimaging studies of the patient (III-2). (a) BrainMRI of the patient at the age of
43 years old (two years after onset) showed hyperintensity in the frontal-lobe-dominant
deepwhite matter and corpus callosum by FLAIR and also showedmarked atrophy. Diffu-
sionweighted imaging showed hyperintensity in the basal ganglia and deepwhite matter
of the frontal lobe. (b) Brain CT of 43 years old showed refined calcifications in the basal
ganglia and deep white matter. (c) FDG-PET of 43 years old showed hypometabolism
throughout the whole cerebral cortex, except for the motor area.
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two unaffected members (the cousins of II-5) did not carry this muta-
tion. This mutation was not registered in dbSNP142, the 1000 Genomes
project, or theHumanGenetic Variation Browser, which includes genet-
ic variations determined by exome sequencing of 1208 Japanese indi-
viduals. The effect of the novel missense mutation was evaluated by in
silico analysis. Polyphen-2 analysis with the HumVar-trained model
showed that the A792D substitutionwas probably damaging to the pro-
tein structure. In Mutation Taster, A792Dwas predicted to be a disease-
causing mutation (probability N0.999).
4. Discussion
We identified a novel missense mutation in the CSF1R gene in a
Japanese family with leukoencephalopathy presenting as adult-onset
cognitive impairment. Themutationwas located within the tyrosine ki-
nase domain, which is the location of all pathological mutations. The
two affectedmembers in the family forwhichDNAwas available carried
themutation, and themutation had not been reported in the large-scale
genome and exome sequencing databases. In silico analyses of pathoge-
nicity predicted that thismutationwould be pathogenic. Although com-
plete segregation analysis was not performed, these facts strongly
suggest that the mutation causes HDLS.
We showed the clinical features of the proband (III-2) and the ped-
igree. The proband exhibited cognitive impairment with apathy, execu-
tive dysfunction, and mild personality changes as the first and only
symptoms; there were few pyramidal or extrapyramidal signs. Consis-
tent with these symptoms, the white matter involvement was mainly
in the anterior part of the frontal lobe with less involvement in the pa-
rietal lobe. The calcification observed in the basal ganglia and deep
white matter of the frontal lobe is characteristic of HDLS and a useful
sign for differentiating HDLS from numerous leukoencephalopathies.
As the calcification of HDLS is refined, thin-slice CT is needed for detec-
tion. The pathogenic significance of the calcification remains unknown.
In this family, the age at disease onset ranged from43 to 54 years old
with a disease duration of 6 to 29 years. The initial symptomwas cogni-
tive impairment in all of the cases. Konno et al. presented a review of 73
reported cases of HDLS from 54 kindreds [10]. Mean age at onset was
45 years old (range, 18–78 years), and mean duration was 6 years
(range, 2–29years). Cognitive impairmentwas themost common initial
symptom shown in 64.3% (36 out of 56) of cases. So far, it has not been
revealed how the type of mutation influences the clinical phenotype,
while it has been suggested that haploinsufficiency of CSF1R is sufficient
to cause HDLS. The symptom profile of the present cases mostly
matched the cases in the review, but interestingly tended to be late-
onset (51 years old on average) with long disease duration (N12 years
on average). Further accumulation of HDLS cases might reveal the
phenotype–genotype correlations.
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